Vascular Inflammation and Lipid-Lowering Therapies

Effects of Statins on Vascular Inflammation

• The American College of Cardiology recommends statins as they achieve measurable decreases in vascular inflammation, with reductions in arterial FDG uptake correlating with cardiovascular risk reduction 1, 2

Lipid-Lowering Mechanisms and Cardiovascular Risk Reduction

• The European Society of Cardiology suggests that the anti-inflammatory effects of lipid-lowering therapies appear predominantly mediated through LDL reduction rather than lipid-independent pathways, with similar cardiovascular event reduction across different lipid-lowering therapies (0.77 risk reduction per 38.7 mg/dL LDL decrease) 3, 4

Research Gaps and Future Directions

• The American Heart Association indicates that imaging studies, such as FDG-PET, measuring arterial inflammation in patients treated with various therapies, including Orencia, are necessary to understand the effects on vascular inflammation 4
• The European League Against Rheumatism recommends clinical trials or observational data on cardiovascular outcomes in patients with rheumatoid arthritis treated with therapies like Orencia to determine their impact on vascular inflammation 2